Kayne Anderson Rudnick Investment Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-59
Closed 590
2020
Q2
$0 Hold
59
﹤0.01% 656
2020
Q1
$0 Sell
59
-28
-32% ﹤0.01% 697
2019
Q4
$0 Buy
+87
New ﹤0.01% 656